Atrial Fibrillation Risk With Cancer Drugs Underestimated

Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials, and so oncologists may underestimate the risk of this adverse event.
Medscape Medical News

source https://www.medscape.com/viewarticle/990547?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?